


Virchow Biotech Revenue
Pharmaceutical Manufacturing • Hyderabad, Telangana, India • 501-1000 Employees
Virchow Biotech revenue & valuation
| Annual revenue | $12,500,000 |
| Revenue per employee | $18,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $40,000,000 |
| Total funding | No funding |
Key Contacts at Virchow Biotech
Rejil Sugathakumaran
Personal Executive To The Managing Director
Murali Tummuru
Owner
C Raghuram
Director Medical Affairs
Company overview
| Headquarters | Survey No 172 part, Next to NORR,, Gagillapur Village,Medchal Mandal,RR Dst, hyderabad, Telangana 500043, IN |
| Phone number | +919700017820 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2001 |
| Employees | 501-1000 |
| Socials |
Virchow Biotech Email Formats
Virchow Biotech uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 56.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 56.2% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 18.4% |
{last name}.{first name}@company.com | doe.john@company.com | 12.1% |
{first name}@company.com | john@company.com | 8.2% |
{first name}_{last name}@company.com | john_doe@company.com | 5.1% |
About Virchow Biotech
Virchow Biotech (P) Ltd is an ISO 13485:2012 and WHO-GMP certified leading global player in Biopharma sector having around 20 years of operational experience and is situated at Hyderabad, India. We also have offices located in USA. Throughout the years, the company has been successful in Research and development, clinical trials, large-scale production and Commercialization of Plasma Products, Recombinants, Biologicals and Bio-Pharmaceuticals. With 1160 employees on the board, VBPL has an expansive infrastructure, which comprises of WHO cGMP and USFDA certified state-of-art clean-room manufacturing facilities and excellent fill-finish lines for PFS, vials, cartridges and lyophilized drug products. VBPL focuses on the manufacturing of a wide range of biologicals and bio-generics by genetic engineering, classical fermentation or extraction technologies. Apart from this, we also offer Contract Research and Manufacturing services, co-development of products for various markets and customers around the world. Virchow Biotech is the part of Virchow Group incorporated in 1981. Other group companies are leading manufacturers of Sulphamethoxazole, Ranitidine, Cephalosporins and various other APIs. VBPL's achievements include being the first company in the world to commercialize biogenerics of PDGF, Teriparatide, Pegylated Interferon and Rasburicase. VBPL has a wide product portfolio across Woundcare, Gynaecology, Urology, Oncology, Vaccines and Probiotics etc. Our mission is to provide high quality Biopharma products at an affordable price. Serving economically challenged patients across the globe through Biotechnology by extending our product base across various therapeutic segments.
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Virchow Biotech has 192 employees across 11 departments.
Departments
Number of employees
Funding Data
Virchow Biotech has never raised funding before.
Virchow Biotech Tech Stack
Discover the technologies and tools that power Virchow Biotech's digital infrastructure, from frameworks to analytics platforms.
CDN
Web servers
JavaScript libraries
JavaScript libraries
Hosting
Programming languages
Font scripts
JavaScript libraries
UI frameworks
Maps
CDN
JavaScript libraries
Frequently asked questions
4.8
40,000 users



